Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 33.71 % in the past year, substantial increase in net sales/revenue by 15.9 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -13.89 %, Marginal decrease of -46.55% in other income during this quarter.
- Profit over the Year and quarter: Challenges in sustaining profitability for KIMIA BIOSCIENCES LIMITED. Profit dropped by -129.12 % Year to Year, KIMIA BIOSCIENCES LIMITED’s profitability dropped by -191.96 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -129.23 % Year to Year. EPS decreased by -192.68 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 22.663 Cr | Rs. 26.145 Cr | Rs. 30.302 Cr | + 15.9 % | + 33.71 % |
| Expenses | Rs. 28.03 Cr | Rs. 27.19 Cr | Rs. 26.14 Cr | -3.86 % | -6.74 % |
| Operating Profit | Rs. -5.37 Cr | Rs. -1.05 Cr | Rs. 4.16 Cr | + 496.19 % | + 177.47 % |
| OPM % | -23.7 % | -4.02 % | 13.73 % | + 17.75 % | + 37.43 % |
| Other Income | Rs. 0.36 Cr | Rs. 0.58 Cr | Rs. 0.31 Cr | -46.55 % | -13.89 % |
| Interest | Rs. 1.26 Cr | Rs. 1.31 Cr | Rs. 1.34 Cr | + 2.29 % | + 6.35 % |
| Depreciation | Rs. 0.87 Cr | Rs. 0.82 Cr | Rs. 0.82 Cr | + 0 % | -5.75 % |
| Profit before tax | Rs. -7.14 Cr | Rs. -2.6 Cr | Rs. 2.31 Cr | + 188.85 % | + 132.35 % |
| Tax % | -24.61 % | -24.95 % | 22.12 % | + 47.07 % | + 46.73 % |
| Net Profit | Rs. -6.17 Cr | Rs. -1.95 Cr | Rs. 1.8 Cr | + 192.31 % | + 129.17 % |
| EPS in Rs | Rs. -1.3 | Rs. -0.41 | Rs. 0.38 | + 192.68 % | + 129.23 % |
Today, we’re looking at KIMIA BIOSCIENCES LIMITED’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 33.71 %. However, it did see a marginal increase of 15.9 % from the previous quarter. Expenses decreased slightly by -3.86 % quarter-on-quarter, aligning with the annual decline of -6.74 %. Operating profit, while up 177.47 % compared to last year, faced a quarter-on-quarter increase of 496.19 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 37.43 %, but an expansion of 17.75 % sequentially. Other income fell by -46.55 % compared to the last quarter, despite an annual decline of -13.89 %. Interest expenses surged remarkably by 2.29 % from the previous quarter, yet the year-over-year increase remains at a moderate 6.35 %. Depreciation costs climbed by 0 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -5.75 %. Profit before tax grew annually by 132.35 % but saw an increase from the preceding quarter by 188.85 %.
Tax expenses as a percentage of profits increased slightly by 46.73 % compared to last year, with a more notable quarter-on-quarter increase of 47.07 %. Net profit rose by 129.17 % year-on-year but experienced a 192.31 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 129.23 % but a quarterly rise of 192.68 %. In summary, KIMIA BIOSCIENCES LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 22.663 Cr | Rs. 26.145 Cr | Rs. 30.302 Cr | + 15.9 % | + 33.71 % |
| Expenses | Rs. 28.03 Cr | Rs. 27.19 Cr | Rs. 26.14 Cr | -3.86 % | -6.74 % |
| Operating Profit | Rs. -5.37 Cr | Rs. -1.05 Cr | Rs. 4.16 Cr | + 496.19 % | + 177.47 % |
| Net Profit | Rs. -6.17 Cr | Rs. -1.95 Cr | Rs. 1.8 Cr | + 192.31 % | + 129.17 % |
| EPS in Rs | Rs. -1.3 | Rs. -0.41 | Rs. 0.38 | + 192.68 % | + 129.23 % |
In reviewing KIMIA BIOSCIENCES LIMITED’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 33.71 % year-on-year growth, however, there was a minor increase of 15.9 % from the previous quarter. Expenses decreased by -6.74 % compared to the previous year, with a decrease of -3.86 % quarter-on-quarter. Operating Profit surged by 177.47 % annually, and saw a 496.19 % increase from the last quarter.
Net Profit showed yearly increase of 129.17 %, and experienced a 192.31 % increase from the previous quarter. Earnings Per Share (EPS) rose by 129.23 % annually, however rose by 192.68 % compared to the last quarter. In essence, while KIMIA BIOSCIENCES LIMITED exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
